MedTrace Logo

Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Liver

NCT03151213 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-03-13

No results posted yet for this study

Summary

The study aimed to investigate the preemptive analgesia efficacy of of preemptive pregabalin for the postoperative pain management after radiofrequency ablation (RFA) of liver cancer.

Conditions

  • Hepatocellular Cancer

Interventions

DRUG

Pregabalin 150mg

Pregabalin 150mg before RFA of liver cancer

OTHER

Placebo

Placebo before RFA of liver cancer

Sponsors & Collaborators

  • Sherief Abd-Elsalam

    lead OTHER

Principal Investigators

  • Amr Magdy Abdelfattah, consultant · Tanta University Faculty of Medicine

  • Sherief Abd-Elsalam, Consultant · Tanta university Faculty of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03151213 on ClinicalTrials.gov